Kongressthemen
Investigate Foundational Technologies, Applications, and Manufacturing Strategies to Create Advanced, Controllable Drugs at the Only Technical Meeting to Explore the Therapeutic Applications of Synthetic Biology.
This year, the synthetic biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/853527-3?pid=4832
Speakers: Aaron Cooper, Director Synthetic Biology, ArsenalBio, Jak Knowles, CEO, Affini-T Therapeutics, Sheila Mikhail, CEO, AskBio and more
https://go.evvnt.com/853527-2?pid=4832
Frau Georgina Fitzgerald
KategorienAllgemeinmedizin
